celecoxib has been researched along with African Lymphoma in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib can inhibit the proliferation of Raji cells in a dose-dependent and time-dependent manner." | 1.36 | [Effect of celecoxib and adriamycin on proliferation and apoptosis of Raji cells and its mechanism]. ( Fu, B; Huang, R; Huang, X; Li, X; Yang, X, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X | 1 |
| Li, X | 1 |
| Huang, R | 1 |
| Yang, X | 1 |
| Fu, B | 1 |
| Kardosh, A | 2 |
| Wang, W | 2 |
| Uddin, J | 1 |
| Petasis, NA | 1 |
| Hofman, FM | 1 |
| Chen, TC | 2 |
| Schönthal, AH | 2 |
| Su, YS | 1 |
3 other studies available for celecoxib and African Lymphoma
| Article | Year |
|---|---|
[Effect of celecoxib and adriamycin on proliferation and apoptosis of Raji cells and its mechanism].
Topics: Apoptosis; Burkitt Lymphoma; Caspase 9; Celecoxib; Cell Line, Tumor; Cell Proliferation; Dose-Respon | 2010 |
Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Celecoxib; Cell Cycle Proteins; Cell Line, Tumor; | 2005 |
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model.
Topics: Animal Feed; Animals; Apoptosis; Burkitt Lymphoma; Celecoxib; Cell Line, Tumor; Central Nervous Syst | 2006 |